Additionally, the PET technique enables metabolic pathway visualization of the increased glucose consumption in malignant tumors [15] and the activities of diverse glucose transporters such as glucose transporter I (GLUT-1) and intracellular glucose metabolic enzymes such as hexokinases have been shown to determine the level of FDG uptake in cancer tissue [34]. This evidence concerns the gene SLC2A1 and cancer.